NetworkNewsBreaks – NeuroMetrix, Inc. (NASDAQ: NURO) Shares Tick Higher on News of U.S. Patent for Quell Wearable Pain Relief Technology

NeuroMetrix (NASDAQ: NURO) shares are up 4% on news that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,675,801 covering claims for technology regarding Quell®, the company’s wearable pain relief device. The novel mechanisms that enable Quell® users to safely achieve pain relief therapy over extended periods of time are covered in the newly issued patent. Such claims include the technology to monitor the amount of time that Quell is worn both continually and in total, as well as technology that delivers notifications to the user to maximize safety. “Quell is unique in the fact that the technology is designed for 24/7 therapy. We know from the Quell Health Cloud data that most of our users wear Quell for a substantial portion of the day to help them manage their chronic pain. The technology in this patent helps us ensure that this usage is both safe and effective,” president and CEO Shai N. Gozani, M.D., Ph.D. stated in the news release.

To view the full press release, visit: http://nnw.fm/I9GcM

About NeuroMetrix

NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company’s lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. Quell is integrated into a digital health platform that helps patients optimize their therapy and decrease the impact of chronic pain on their quality of life. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.neurometrix.com.

About NetworkNewsBreaks

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s